Latest

MDMA

·July 12, 2023·7 min read

Psychedelic Breakthrough: MDMA Revolutionizes PTSD Treatment

Psychedelic therapies, including the use of MDMA, are set to revolutionize psychiatric treatments, especially for those with post-traumatic stress disorder (PTSD). The anticipation builds for the FDA's approval of MDMA-assisted therapy for PTSD, which will mark a first for a psychedelic drug in mainstream medicine.

Featured Neuroscience Psychology

·January 9, 2023·12 min read

The Rebirth of Psychedelic Medicine

Often considered dangerous, mind-altering drugs, researchers are turning to the study of psychedelic therapies as a potential to treat an array of psychiatric conditions including depression and PTSD.

Featured Neuroscience Psychology

·September 1, 2022·4 min read

Most Promising PTSD Treatment May Use ‘Ecstasy’ or ‘Magic Mushrooms’ Alongside Psychotherapy

Prescribing psychedelic therapies including MDMA and psilocybin in combination with counseling and psychotherapy improve symptoms for those with PTSD.

Featured Neuroscience Psychology

·August 2, 2022·6 min read

Psychedelic Drugs’ Therapeutic Potential for a Range of Psychiatric Disorders

Researchers discuss how psychedelics can affect the brain and provide therapeutic benefits for those suffering from a range of psychiatric disorders.

Featured Neuroscience Open Neuroscience Articles Psychology

·February 11, 2020·3 min read

Cannabis increases susceptibility to false memory

In comparison to a placebo group, test subjects exposed to marijuana were more likely to form false memories based on incorrect information.

This shows psychedelic swirls around a person's head

Featured Neuroscience Psychology

·January 17, 2020·2 min read

Psychedelic drugs could help treat PTSD

Backing up previous research, a new study reveals psychedelics can have beneficial effects for treating PTSD when combined with traditional trauma-focused psychotherapy. Findings suggest MDMA assisted therapy is significantly more effective at treating patients with persistent PTSD than psychotherapy alone.

Featured Neuroscience Psychology

·December 11, 2019·7 min read

Rave new world: Scientists pry apart party drug’s therapeutic, addictive qualities

Researchers have distinguished two different molecular pathways responsible for addiction and the prosocial feelings generated by MDMA. The findings could lead to novel treatments for psychiatric disorders marked by withdrawal and social awkwardness.

Featured Neuroscience Psychology

·September 1, 2019·5 min read

Psychedelic drugs: would you accept a prescription? It depends if you’ve tried them before

Numerous studies have linked controlled psychedelics to improvements in mental health conditions such as depression and PTSD. In March, the FDA approved Esketamine as a treatment for depression. However, with much stigma surrounding psychedelics, researchers question how many patients would take psychedelic medications if prescribed to them. According to a new study, 40% of people with no experience of psychedelics would be unlikely to take the prescription due to fears of 'brain damage' or a 'bad trip'.

Featured Neuroscience Psychology

·August 12, 2019·5 min read

Nearly 1 in 2 swingers uses recreational drugs to intensify sex

Half of all people who practice sexual swinging use recreational drugs to enhance their experience. Researchers report women are more likely to use drugs than either straight or bisexual men, increasing the risk of them participating in unprotected sex and contracting a sexually transmitted infection.

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

This shows a brain overlayed on a person's head with a swirly, psychedelic background

Featured Neuroscience Psychology

·April 4, 2019·5 min read

Psychedelic drug MDMA may reawaken ‘critical period’ in brain to help treat PTSD

MDMA, a psychedelic drug, has successfully been used to reopen the 'critical period' of learning the reward values of social behaviors. Researchers report, in mature mice given MDMA, oxytocin triggers signaling in synapses that help encode social learning and memory, a process that does not usually occur in older animals. The findings could help in the development of treatments for PTSD and other disorders.